论文部分内容阅读
在近日举行的世界最大的制药原料商品交易展CPhI上,印度政府官员称,到2016年,印度化学原药出口目标将由目前的100亿美元提升至250亿美元。虽然印度化学原药业面临多方面的挑战,如西方国家指责其专利侵权,以及一些著名药企认为其存在各方面的质量问题等,但印度仍致力于大力发展化学原药业,大幅提升该行业的规模和销售收入。印度对化学原药业的乐观态度缘于该行业近几年来的优异表现。据印度品牌权益基金会(IBEF)
At a recent CPhI, the world’s largest pharmaceutical raw materials trade show, the government official said that by 2016, India’s chemical export target will rise from the current 10 billion U.S. dollars to 25 billion U.S. dollars. Although India’s chemical industry is facing many challenges, such as Western countries accused of patent infringement, as well as some well-known pharmaceutical companies that exist in all aspects of its quality problems, but India is still committed to vigorously develop the chemical industry, substantially enhance the Industry size and sales revenue. India’s optimism about the chemical industry is due to the industry’s outstanding performance in recent years. According to the Indian Brand Equity Fund (IBEF)